| # | Drug | Count |
|---|---|---|
| 0 | SILDENAFIL CITRATE | 93 |
| 1 | DABIGATRAN ETEXILATE | 87 |
| 2 | DABIGATRAN ETEXILATE MESYLATE | 85 |
| 3 | BOSENTAN | 80 |
| 4 | FUROSEMIDE | 79 |
| 5 | TACROLIMUS | 75 |
| 6 | SILDENAFIL | 73 |
| 7 | ASPIRIN | 64 |
| 8 | AMBRISENTAN | 63 |
| 9 | ASPIRIN 81 MG | 59 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CALCIUM CHLORIDE, MAGNESIUM CHLORIDE, POTASSIUM CHLORIDE AND SODIUM CHLORIDE | 1 | 0.0909 |
| 1 | SENNA 8.6MG | 1 | 0.0185 |
| 2 | VUTRISIRAN | 28 | 0.0094 |
| 3 | TRIHEPTANOIN | 5 | 0.0090 |
| 4 | MIGALASTAT HYDROCHLORIDE | 4 | 0.0072 |
| 5 | PRILOCAINE HYDROCHLORIDE | 1 | 0.0062 |
| 6 | PATISIRAN | 17 | 0.0060 |
| 7 | PENTAMIDINE ISETHIONATE | 7 | 0.0056 |
| 8 | PROTAMINE SULFATE | 9 | 0.0049 |
| 9 | MILRINONE LACTATE | 1 | 0.0036 |
| # | Drug class | Count |
|---|---|---|
| 0 | Endothelin Receptor Antagonist [EPC] | 97 |
| 1 | Loop Diuretic [EPC] | 96 |
| 2 | Phosphodiesterase 5 Inhibitor [EPC] | 81 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 79 |
| 4 | Corticosteroid [EPC] | 75 |
| 5 | Platelet Aggregation Inhibitor [EPC] | 65 |
| 6 | Aldosterone Antagonist [EPC] | 50 |
| 7 | Insulin Analog [EPC] | 41 |
| 8 | beta-Adrenergic Blocker [EPC] | 41 |
| 9 | Cardiac Glycoside [EPC] | 37 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Medium-chain Triglyceride [EPC] | 5 | 0.0090 |
| 1 | Lymphocyte Growth Factor [EPC] | 2 | 0.0016 |
| 2 | Vitamin K [EPC] | 9 | 0.0010 |
| 3 | Antimetabolite Immunosuppressant [EPC] | 14 | 0.0007 |
| 4 | Hepatitis C Virus NS3/4A Protease Inhibitor [EPC] | 10 | 0.0006 |
| 5 | Phosphodiesterase 5 Inhibitor [EPC] | 81 | 0.0006 |
| 6 | Polyene Antifungal [EPC] | 22 | 0.0005 |
| 7 | Cardiac Glycoside [EPC] | 37 | 0.0005 |
| 8 | Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] | 5 | 0.0005 |
| 9 | Anticholinergic [EPC] | 8 | 0.0005 |